Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 15923690

Meropenem.

Dheeraj Shah·Manish Narang
View original source ↗Export metadata ↓

Abstract

Meropenem is a new carbapenem antibacterial agent with wide spectrum of activity against gram-negative, gram-positive and anaerobic organisms. It is stable against most beta-lactamases produced by gram-negative bacteria and has greatest utility in treating severe infections in hospitalized children. It has good CSF penetrability and useful in treatment of childhood meningitis and infections in neutropenic children. Due to concern relating to emergence of resistance, it should be used as a reserve drug in difficult-to-treat infections caused by resistant organisms or when conventional treatment fails.

Explore related subjects

Bacterial InfectionsCentral Nervous System Bacterial InfectionsChildChild, PreschoolDrug Resistance, BacterialHumansInfantInfant, NewbornIntensive Care UnitsMeropenemNeutropeniaThienamycinsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dheeraj Shah, Manish Narang. 2005. Meropenem.. https://pubmed.ncbi.nlm.nih.gov/15923690/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Risk factors for umbilical cord infection among newborns of southern Nepal.

Although umbilical cord infection contributes to neonatal mortality and morbidity and risk can be reduced with topical chlorhexidine, behavioral or other factors associated with cord infection in low-resource settings have not been examined. Data on potential risk factors for omphalitis were collected during a community-based, umbilical cord care trial in Nepal during 2002-2005. Newborns were evaluated in the home for signs of umbilical cord infection (pus, redness, and swelling). Omphalitis was defined as either pus discharge with erythema of the abdominal skin or severe redness (>2 cm extension from the cord stump) with or without pus. Multivariable regression modeling was used to examine associations between omphalitis and maternal, newborn, and household variables. Omphalitis was identified in 954 of 17,198 newborns (5.5%). Infection risk was 29% and 62% higher in infants receiving topical cord applications of mustard oil and other potentially unclean substances, respectively. Skin-to-skin contact (relative risk (RR) = 0.64, 95% confidence interval (CI): 0.43, 0.95) and hand washing by birth attendants (RR = 0.73, 95% CI: 0.64, 0.84) and caretakers (RR = 0.76, 95% CI: 0.60, 0.95) were associated with fewer infections. In this community, unhygienic newborn-care practices lead to continued high risk for omphalitis. In addition to topical antiseptics, simple, low-cost interventions such as hand washing, skin-to-skin contact, and avoiding unclean cord applications should be promoted by community-based health workers.

Bacterial Infections↗
PubMed2006

Environmental exposure to bacteria and viruses may provide oncolytic protection against cancers, and declining exposure to infections may contribute to a rising incidence of cancer.

Over the past century, the incidence of cancer rose markedly in developed countries. Many underlying factors are known, but not all of them. Over the same century, advances in public health and hygiene practically eradicated many infectious illnesses, and exposure to some untargeted infectious agents has also declined. There are reasons to suspect that these two trends are linked. Although some viruses and one bacterium are known to be oncogenic, a high percentage of infectious agents, 71% of viruses tested in one study, have shown oncolytic properties. Some of these agents have minimal or no clinical consequences, and some are - or were - quite ubiquitous. Many types of cancer are unusually susceptible to several different agents, sometimes 10-1000 times more susceptible than normal cells. When wild-type or attenuated viruses are used to treat cancer, they are often more effective with smaller tumors, and it may be that nascent, undetectable cancers are especially vulnerable. Environmental exposure to bacteria and viruses may provide natural protection from cancer by attacking it at this stage, or inducing the body to do so. Immunity to an infectious agent can attenuate its oncolytic effect, but generally does not stop it, so both initial and repeated exposures may be protective. As more direct evidence, treatment of animals with selected live virus vaccines has provided protection from cancer, and in humans, exposure to two specific infectious agents is known to correlate with a reduced risk of cancer. The significant decline in exposure to infectious agents over the past century may have inadvertently weakened this naturally protective mechanism, driving cancer rates up. There is considerable research on the impact of oncogenic agents, but surprisingly little regarding the impact of oncolytic agents on cancer rates. An understanding of the relationship between natural infections and the suppression of cancer may lead to prophylactic measures against cancer, improved public health policies regarding vaccination programs and hygiene, and greater insight into cancer treatment as well.

Bacterial Infections↗